[{"Title":"Пероральні естроген-прогестинові контрацептиви","UniqueID":"v39505169_uk","Index":1.0,"Summary":"

For most estrogen-progestin oral contraceptives, a pill with estrogen and progestin is taken daily for 21 to 24 days. Then, a placebo pill is taken daily for 4 to 7 days to allow for withdrawal bleeding. In a few formulations, the placebo pill contains iron and folate (folic acid); in others, this pill is not truly inactive but contains a lower dose of ethinyl estradiol than the pills used during the other weeks. Estrogen-progestin OCs are also available in extended-cycle formulations (with 84 active pills, one to be taken each day, followed by 7 days of placebo pills) or as continuous-use formulations (active pills every day, with no placebo pills).

","HeadType":"G_Head","SchemeItemProp":"","Children":[{"Title":"Протипоказання до естроген-прогестинових контрацептивів (таблетки, пластир, вагінальне кільце)","UniqueID":"v82330411_uk","Index":1.0,"Summary":"

","HeadType":"H_Head","SchemeItemProp":"","Children":[]}]},{"Title":"Оральні контрацептиви, що містять тільки прогестин","UniqueID":"v39505209_uk","Index":2.0,"Summary":"

To be effective, progestin-only OCs must be taken at the same time of day each day. The same dose is taken daily, and no inactive pills are included. Breakthrough bleeding is a common adverse effect.

","HeadType":"G_Head","SchemeItemProp":"","Children":[{"Title":"Протипоказання до застосування лише прогестинових контрацептивів (таблетки, імплантати, ін'єкції)","UniqueID":"v82330482_uk","Index":1.0,"Summary":"

To be effective, progestin-only OCs must be taken at the same time of day each day. The same dose is taken daily, and no inactive pills are included. Breakthrough bleeding is a common adverse effect.

","HeadType":"H_Head","SchemeItemProp":"","Children":[]}]},{"Title":"Довідковий матеріал загального характеру","UniqueID":"v104774464_uk","Index":3.0,"Summary":"

1. Shoupe D: The Contraception Handbook: Evidence Based Practice Recommendations and Rationales, ed. 3. New York, Humana Press, 2020. doi:10.1007/978-3-030-46391-5

","HeadType":"G_Head","SchemeItemProp":"","Children":[]},{"Title":"Побічні ефекти","UniqueID":"v39505212_uk","Index":4.0,"Summary":"

Although oral contraceptives have some potential adverse effects, the overall risk of these effects is small. Bloating, breast tenderness, nausea, and headache are the most common adverse effects.

","HeadType":"F_Head","SchemeItemProp":"","Children":[{"Title":"Довідкові матеріали щодо побічних ефектів","UniqueID":"v62055485_uk","Index":1.0,"Summary":"

Although oral contraceptives have some potential adverse effects, the overall risk of these effects is small. Bloating, breast tenderness, nausea, and headache are the most common adverse effects.

","HeadType":"G_Head","SchemeItemProp":"","Children":[]}]},{"Title":"Переваги","UniqueID":"v39505243_uk","Index":5.0,"Summary":"

Health benefits associated with OCs include decreased risk of ( 1 ):

","HeadType":"F_Head","SchemeItemProp":"","Children":[{"Title":"Довідковий матеріал щодо переваг","UniqueID":"v82330523_uk","Index":1.0,"Summary":"

Health benefits associated with OCs include decreased risk of ( 1 ):

","HeadType":"G_Head","SchemeItemProp":"","Children":[]}]},{"Title":"Взаємодія лікарських засобів","UniqueID":"v39505258_uk","Index":6.0,"Summary":"

Drug interactions with hormonal contraceptives can decrease contraceptive efficacy or alter the therapeutic efficacy of the concurrent medications.

","HeadType":"F_Head","SchemeItemProp":"","Children":[{"Title":"Довідкові матеріали щодо взаємодії лікарських засобів","UniqueID":"v104774488_uk","Index":1.0,"Summary":"

Drug interactions with hormonal contraceptives can decrease contraceptive efficacy or alter the therapeutic efficacy of the concurrent medications.

","HeadType":"G_Head","SchemeItemProp":"","Children":[]}]},{"Title":"Початок прийому","UniqueID":"v39505262_uk","Index":7.0,"Summary":"

Before oral contraceptives are started, clinicians should take a thorough medical, social, and family history to assess for potential contraindications to use. Blood pressure should be measured. A pregnancy test is not required and should be performed based on risk factors for pregnancy. OCs should not be prescribed unless blood pressure is normal and a urine pregnancy test (if indicated) is negative. A physical examination is not required prior to initiating OCs. Routine blood work is not required in patients without comorbidities. Routine screening for glucose, lipids, liver enzymes or thrombophilia is not necessary in a patient with no medical history ( 1 ).

","HeadType":"F_Head","SchemeItemProp":"","Children":[{"Title":"Пізній або пропущений прийом пероральних контрацептивів","UniqueID":"v104774510_uk","Index":1.0,"Summary":"

","HeadType":"H_Head","SchemeItemProp":"","Children":[]},{"Title":"Післяпологове застосування пероральних контрацептивів","UniqueID":"v104774515_uk","Index":2.0,"Summary":"

","HeadType":"H_Head","SchemeItemProp":"","Children":[]},{"Title":"Довідкові матеріали щодо початку прийому","UniqueID":"v104774528_uk","Index":3.0,"Summary":"

","HeadType":"G_Head","SchemeItemProp":"","Children":[]}]},{"Title":"Ключові моменти","UniqueID":"v8579729_uk","Index":8.0,"Summary":"

Oral contraceptives (OCs) are generally well tolerated but may cause headache, nausea, bloating, or breast tenderness.

","HeadType":"F_Head","SchemeItemProp":"","Children":[]}]